| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.805 | 0.003 | 0.805 | Bronchodilator | 0.36 0.007 CID_154699559 | ||
| 0.771 | 0.004 | 0.831 | Spasmolytic | 0.831 0.004 CID_154699559 | CID_154699559 | |
| 0.733 | 0.002 | 0.733 | Calcium channel L-type activator | 0.639 0.004 CID_154699559 | ||
| 0.701 | 0.001 | 0.701 | Phenylalanine 4-hydroxylase inhibitor | 0.161 0.01 CID_154699559 | ||
| 0.683 | 0.01 | 0.683 | Toll-Like receptor 7 agonist | 0.509 0.03 CID_154699559 | ||
| 0.678 | 0.01 | 0.678 | Toll-Like receptor agonist | 0.523 0.028 CID_154699559 | ||
| 0.654 | 0.015 | 0.654 | Antiobesity | 0.597 0.021 CID_154699559 | ||
| 0.619 | 0.005 | 0.619 | Antiadrenergic | 0.088 0.064 CID_154699559 | ||
| 0.614 | 0.005 | 0.614 | Adrenaline antagonist | 0.085 0.064 CID_154699559 | ||
| 0.596 | 0.006 | 0.596 | Psychostimulant | 0.587 0.006 CID_154699559 | ||
| 0.589 | 0.02 | 0.589 | Aldehyde oxidase inhibitor | |||
| 0.589 | 0.029 | 0.837 | Cyclophilin D inhibitor | 0.837 0.005 CID_154699559 | CID_154699559 | |
| 0.571 | 0.019 | 0.571 | Vasodilator, peripheral | 0.492 0.029 CID_154699559 | ||
| 0.549 | 0.006 | 0.549 | Peroxidase inhibitor | |||
| 0.529 | 0.012 | 0.768 | Vasodilator, coronary | 0.768 0.004 CID_154699559 | CID_154699559 | |
| 0.521 | 0.004 | 0.521 | Calcium channel activator | 0.351 0.049 CID_154699559 | ||
| 0.512 | 0.013 | 0.55 | Hypoxia-inducible factor 1 alpha inhibitor | 0.55 0.01 CID_154699559 | CID_154699559 | |
| 0.532 | 0.04 | 0.794 | Transcription factor NF kappa B inhibitor | 0.794 0.013 CID_154699559 | CID_154699559 | |
| 0.498 | 0.028 | 0.498 | 5 Hydroxytryptamine release stimulant | 0.268 0.081 CID_154699559 | ||
| 0.467 | 0.011 | 0.605 | Interleukin agonist | 0.605 0.005 CID_154699559 | CID_154699559 | |
| 0.466 | 0.042 | 0.538 | Histamine release inhibitor | 0.538 0.018 CID_154699559 | CID_154699559 | |
| 0.423 | 0.003 | 0.423 | Adrenaline agonist | 0.086 0.05 CID_154699559 | ||
| 0.4 | 0.006 | 0.4 | Anesthetic local | |||
| 0.4 | 0.007 | 0.476 | Peptidyltransferase inhibitor | 0.476 0.004 CID_154699559 | CID_154699559 | |
| 0.458 | 0.079 | 0.458 | Caspase 9 stimulant | 0.428 0.095 CID_154699559 | ||
| 0.37 | 0.007 | 0.37 | Acetylcholine M1 receptor antagonist | 0.124 0.103 CID_154699559 | ||
| 0.384 | 0.026 | 0.454 | Vasodilator | 0.454 0.016 CID_154699559 | CID_154699559 | |
| 0.41 | 0.057 | 0.41 | GABA C receptor rho-3 antagonist | |||
| 0.357 | 0.014 | 0.357 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.351 | 0.01 | 0.351 | Cholinergic antagonist | |||
| 0.347 | 0.008 | 0.347 | M18 aspartyl aminopeptidase inhibitor | |||
| 0.34 | 0.002 | 0.34 | Adenylate cyclase stimulant | 0.242 0.004 CID_154699559 | ||
| 0.338 | 0.002 | 0.338 | Beta 3 adrenoreceptor antagonist | |||
| 0.34 | 0.004 | 0.34 | Alpha adrenoreceptor agonist | |||
| 0.407 | 0.074 | 0.46 | 5 Hydroxytryptamine release inhibitor | 0.46 0.047 CID_154699559 | CID_154699559 | |
| 0.341 | 0.011 | 0.341 | Acetylcholine antagonist | |||
| 0.383 | 0.053 | 0.631 | Cholesterol antagonist | 0.631 0.015 CID_154699559 | CID_154699559 | |
| 0.329 | 0.007 | 0.329 | Acetylcholine muscarinic antagonist | 0.106 0.084 CID_154699559 | ||
| 0.351 | 0.039 | 0.351 | Sodium/bile acid cotransporter inhibitor | 0.266 0.111 CID_154699559 | ||
| 0.316 | 0.004 | 0.316 | Acetylcholine M3 receptor antagonist | |||
| 0.374 | 0.075 | 0.374 | Calpain 2 inhibitor | |||
| 0.308 | 0.01 | 0.308 | Nitric-oxide synthase stimulant | 0.301 0.011 CID_154699559 | ||
| 0.337 | 0.043 | 0.337 | Cardiotonic | 0.21 0.11 CID_154699559 | ||
| 0.292 | 0.004 | 0.292 | Toll-Like receptor 3 antagonist | 0.127 0.025 CID_154699559 | ||
| 0.321 | 0.035 | 0.321 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.319 | 0.035 | 0.463 | Cyclic AMP phosphodiesterase inhibitor | 0.463 0.009 CID_154699559 | CID_154699559 | |
| 0.282 | 0.003 | 0.282 | Beta adrenoreceptor antagonist | |||
| 0.272 | 0.003 | 0.272 | Beta 2 adrenoreceptor antagonist | |||
| 0.284 | 0.02 | 0.284 | Insulin sensitizer | 0.26 0.029 CID_154699559 | ||
| 0.276 | 0.016 | 0.276 | Adenylate cyclase inhibitor | 0.159 0.039 CID_154699559 | ||
| 0.293 | 0.035 | 0.293 | Anesthetic general | 0.26 0.046 CID_154699559 | ||
| 0.325 | 0.074 | 0.719 | Antithrombotic | 0.719 0.007 CID_154699559 | CID_154699559 | |
| 0.28 | 0.03 | 0.28 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.185 0.087 CID_154699559 | ||
| 0.247 | 0.003 | 0.247 | Beta 1 adrenoreceptor antagonist | |||
| 0.31 | 0.067 | 0.439 | Interleukin 2 agonist | 0.439 0.018 CID_154699559 | CID_154699559 | |
| 0.296 | 0.053 | 0.541 | Free radical scavenger | 0.541 0.012 CID_154699559 | CID_154699559 | |
| 0.271 | 0.028 | 0.271 | Neurotrophic factor enhancer | 0.271 0.028 CID_154699559 | ||
| 0.283 | 0.042 | 0.283 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.302 | 0.061 | 0.599 | Antioxidant | 0.599 0.011 CID_154699559 | CID_154699559 | |
| 0.236 | 0.002 | 0.236 | Alpha 2a adrenoreceptor agonist | |||
| 0.24 | 0.014 | 0.546 | Expectorant | 0.546 0.003 CID_154699559 | CID_154699559 | |
| 0.23 | 0.005 | 0.23 | Glutamate decarboxylase inhibitor | |||
| 0.223 | 0.006 | 0.223 | Sphingomyelinase inhibitor | 0.204 0.009 CID_154699559 | ||
| 0.225 | 0.009 | 0.225 | Mucolytic | 0.215 0.01 CID_154699559 | ||
| 0.229 | 0.018 | 0.229 | Alpha 2b adrenoreceptor antagonist | |||
| 0.216 | 0.005 | 0.216 | Alpha 1 adrenoreceptor agonist | |||
| 0.215 | 0.01 | 0.215 | Aminoacyl-tRNA synthetase inhibitor | 0.138 0.023 CID_154699559 | ||
| 0.207 | 0.004 | 0.207 | Alpha 2 adrenoreceptor agonist | |||
| 0.198 | 0.003 | 0.198 | Beta adrenoreceptor agonist | 0.045 0.03 CID_154699559 | ||
| 0.262 | 0.067 | 0.262 | Superoxide dismutase inhibitor | |||
| 0.258 | 0.068 | 0.35 | Antiamyloidogenic | 0.35 0.039 CID_154699559 | CID_154699559 | |
| 0.346 | 0.156 | 0.346 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.224 | 0.034 | 0.364 | Protein kinase stimulant | 0.364 0.011 CID_154699559 | CID_154699559 | |
| 0.193 | 0.008 | 0.193 | Carbonic anhydrase stimulant | |||
| 0.19 | 0.006 | 0.19 | Adrenaline uptake inhibitor | 0.058 0.047 CID_154699559 | ||
| 0.212 | 0.031 | 0.32 | Alpha-N-acetylglucosaminidase inhibitor | 0.32 0.014 CID_154699559 | CID_154699559 | |
| 0.263 | 0.085 | 0.263 | Insulysin inhibitor | |||
| 0.182 | 0.005 | 0.182 | Acetylcholine M5 receptor antagonist | |||
| 0.204 | 0.028 | 0.38 | Cell wall synthesis inhibitor | 0.38 0.007 CID_154699559 | CID_154699559 | |
| 0.176 | 0.002 | 0.176 | Beta 2 adrenoreceptor agonist | 0.062 0.041 CID_154699559 | ||
| 0.214 | 0.043 | 0.214 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.203 | 0.033 | 0.421 | Monophenol monooxygenase inhibitor | 0.421 0.01 CID_154699559 | CID_154699559 | |
| 0.175 | 0.006 | 0.175 | Glutamate (mGluR7) agonist | |||
| 0.201 | 0.036 | 0.326 | ATPase inhibitor | 0.326 0.005 CID_154699559 | CID_154699559 | |
| 0.196 | 0.031 | 0.196 | GABA C receptor rho-2 antagonist | |||
| 0.193 | 0.028 | 0.359 | Alkylator | 0.359 0.009 CID_154699559 | CID_154699559 | |
| 0.19 | 0.028 | 0.19 | Nav1.3 sodium channel blocker | |||
| 0.298 | 0.137 | 0.634 | Antibacterial | 0.634 0.015 CID_154699559 | CID_154699559 | |
| 0.236 | 0.079 | 0.236 | Calpain inhibitor | |||
| 0.177 | 0.02 | 0.177 | Protein kinase C gamma inhibitor | |||
| 0.198 | 0.042 | 0.341 | Melanin inhibitor | 0.341 0.017 CID_154699559 | CID_154699559 | |
| 0.239 | 0.083 | 0.626 | Hypoglycemic | 0.626 0.007 CID_154699559 | CID_154699559 | |
| 0.165 | 0.011 | 0.165 | Anabolic | 0.101 0.061 CID_154699559 | ||
| 0.174 | 0.021 | 0.174 | Carbonic anhydrase III inhibitor | 0.094 0.07 CID_154699559 | ||
| 0.162 | 0.01 | 0.162 | Acetylcholine M2 receptor antagonist | |||
| 0.166 | 0.014 | 0.166 | 5 Hydroxytryptamine uptake inhibitor | |||
| 0.218 | 0.069 | 0.218 | Amyloid beta aggregation inhibitor | 0.156 0.104 CID_154699559 | ||
| 0.176 | 0.033 | 0.176 | Cholesterol synthesis inhibitor | 0.114 0.071 CID_154699559 | ||
| 0.145 | 0.002 | 0.145 | Alpha 1d adrenoreceptor agonist | |||
| 0.167 | 0.025 | 0.167 | Alpha 2c adrenoreceptor antagonist | |||
| 0.163 | 0.021 | 0.163 | Gastric antisecretory | |||
| 0.141 | 0.005 | 0.141 | Estrogen-related receptor beta agonist | |||
| 0.184 | 0.05 | 0.396 | Amylase inhibitor | 0.396 0.009 CID_154699559 | CID_154699559 | |
| 0.155 | 0.022 | 0.155 | Creatine kinase inhibitor | |||
| 0.137 | 0.003 | 0.137 | Diamine oxidase inhibitor | |||
| 0.235 | 0.102 | 0.498 | Immunostimulant | 0.498 0.029 CID_154699559 | CID_154699559 | |
| 0.152 | 0.022 | 0.152 | Urease inhibitor | |||
| 0.149 | 0.021 | 0.149 | Electron transport complex I inhibitor | 0.099 0.084 CID_154699559 | ||
| 0.163 | 0.037 | 0.163 | Antibacterial (Helicobacter pylori) | |||
| 0.157 | 0.032 | 0.157 | Vanilloid 1 agonist | 0.144 0.044 CID_154699559 | ||
| 0.281 | 0.157 | 0.281 | Analgesic | |||
| 0.129 | 0.005 | 0.129 | GABA B receptor agonist | |||
| 0.139 | 0.016 | 0.139 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.161 | 0.039 | 0.406 | Cyclooxygenase 3 inhibitor | 0.406 0.004 CID_154699559 | CID_154699559 | |
| 0.145 | 0.027 | 0.145 | Transcription factor STAT6 inhibitor | |||
| 0.179 | 0.062 | 0.179 | Phospholipase C inhibitor | 0.143 0.12 CID_154699559 | ||
| 0.148 | 0.031 | 0.148 | Carbonic anhydrase XV inhibitor | |||
| 0.145 | 0.029 | 0.145 | Alpha 2 adrenoreceptor antagonist | |||
| 0.147 | 0.031 | 0.147 | GABA C receptor antagonist | |||
| 0.158 | 0.043 | 0.158 | Interleukin 4 antagonist | 0.145 0.055 CID_154699559 | ||
| 0.145 | 0.031 | 0.37 | Mediator release inhibitor | 0.37 0.005 CID_154699559 | CID_154699559 | |
| 0.143 | 0.028 | 0.143 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.123 | 0.009 | 0.123 | NMDA 2A receptor antagonist | |||
| 0.151 | 0.04 | 0.151 | Cystathionine beta-synthase inhibitor | 0.113 0.064 CID_154699559 | ||
| 0.139 | 0.028 | 0.139 | NMDA receptor antagonist | |||
| 0.138 | 0.027 | 0.138 | GABA C receptor rho-1 antagonist | |||
| 0.145 | 0.036 | 0.145 | GABA C receptor agonist | |||
| 0.133 | 0.026 | 0.133 | Alpha 2a adrenoreceptor antagonist | |||
| 0.118 | 0.011 | 0.118 | Maillard reaction inhibitor | 0.076 0.026 CID_154699559 | ||
| 0.135 | 0.029 | 0.135 | Prolactin inhibitor | |||
| 0.212 | 0.106 | 0.335 | DNA synthesis inhibitor | 0.335 0.034 CID_154699559 | CID_154699559 | |
| 0.16 | 0.056 | 0.16 | MAO inhibitor | |||
| 0.107 | 0.004 | 0.107 | Alpha 1b adrenoreceptor agonist | |||
| 0.134 | 0.033 | 0.134 | Estrogen antagonist | |||
| 0.148 | 0.049 | 0.148 | Ca2+-transporting ATPase inhibitor | 0.14 0.074 CID_154699559 | ||
| 0.1 | 0.003 | 0.1 | Beta 1 adrenoreceptor agonist | |||
| 0.12 | 0.024 | 0.12 | NMDA 2 receptor antagonist | |||
| 0.173 | 0.076 | 0.173 | Succinate dehydrogenase inhibitor | |||
| 0.118 | 0.022 | 0.118 | Histamine H2 receptor antagonist | |||
| 0.12 | 0.025 | 0.171 | Phosphodiesterase 6D inhibitor | 0.171 0.006 CID_154699559 | CID_154699559 | |
| 0.119 | 0.026 | 0.119 | Ornithine decarboxylase inhibitor | 0.091 0.054 CID_154699559 | ||
| 0.149 | 0.055 | 0.149 | Pregnane X receptor agonist | |||
| 0.116 | 0.025 | 0.116 | Somatostatin 1 agonist | |||
| 0.138 | 0.047 | 0.138 | Papain-like protease (SARS coronavirus) inhibitor | |||
| 0.144 | 0.057 | 0.144 | Toll-Like receptor 2 antagonist | |||
| 0.119 | 0.033 | 0.119 | Estrogen receptor beta antagonist | |||
| 0.162 | 0.076 | 0.162 | Neurotensin receptor agonist | |||
| 0.131 | 0.047 | 0.131 | MAO A inhibitor | |||
| 0.13 | 0.047 | 0.13 | Ferrochelatase inhibitor | |||
| 0.199 | 0.116 | 0.225 | DNA damaging | 0.225 0.096 CID_154699559 | CID_154699559 | |
| 0.104 | 0.022 | 0.104 | Amidase inhibitor | |||
| 0.132 | 0.049 | 0.167 | Microtubule formation inhibitor | 0.167 0.03 CID_154699559 | CID_154699559 | |
| 0.175 | 0.1 | 0.175 | Interleukin antagonist | |||
| 0.125 | 0.049 | 0.125 | Chelator | |||
| 0.078 | 0.003 | 0.078 | Beta 3 adrenoreceptor agonist | |||
| 0.125 | 0.051 | 0.178 | Photosensitizer | 0.178 0.018 CID_154699559 | CID_154699559 | |
| 0.084 | 0.011 | 0.084 | NMDA receptor subunit 3A antagonist | |||
| 0.119 | 0.046 | 0.119 | DOPA decarboxylase inhibitor | |||
| 0.122 | 0.05 | 0.122 | Nav1.4 sodium channel blocker | |||
| 0.072 | 0.004 | 0.072 | Alpha 1a adrenoreceptor agonist | |||
| 0.08 | 0.011 | 0.08 | Stearoyl-CoA desaturase inhibitor | |||
| 0.079 | 0.011 | 0.192 | Alpha-mannosidase inhibitor | 0.192 0.003 CID_154699559 | CID_154699559 | |
| 0.091 | 0.023 | 0.091 | MAP kinase kinase 7 inhibitor | |||
| 0.104 | 0.037 | 0.11 | Glutamate release inhibitor | 0.11 0.03 CID_154699559 | CID_154699559 | |
| 0.129 | 0.063 | 0.129 | Aldehyde dehydrogenase inhibitor | 0.103 0.093 CID_154699559 | ||
| 0.147 | 0.081 | 0.252 | Interferon gamma antagonist | 0.252 0.028 CID_154699559 | CID_154699559 | |
| 0.206 | 0.14 | 0.206 | Gastrin inhibitor | |||
| 0.117 | 0.053 | 0.135 | Acetylcholine release stimulant | 0.135 0.029 CID_154699559 | CID_154699559 | |
| 0.121 | 0.057 | 0.121 | TRPA1 agonist | |||
| 0.151 | 0.087 | 0.151 | Arachidonic acid antagonist | |||
| 0.095 | 0.034 | 0.095 | Histidine decarboxylase inhibitor | |||
| 0.1 | 0.039 | 0.1 | Acetylcholine nicotinic antagonist | |||
| 0.083 | 0.023 | 0.083 | Alcohol oxidase inhibitor | |||
| 0.098 | 0.038 | 0.098 | Myeloperoxidase inhibitor | |||
| 0.159 | 0.1 | 0.422 | Hepatoprotectant | 0.422 0.011 CID_154699559 | CID_154699559 | |
| 0.07 | 0.011 | 0.202 | Mannosidase inhibitor | 0.202 0.003 CID_154699559 | CID_154699559 | |
| 0.174 | 0.115 | 0.315 | Hypolipemic | 0.315 0.044 CID_154699559 | CID_154699559 | |
| 0.082 | 0.024 | 0.082 | Dopamine uptake inhibitor | |||
| 0.111 | 0.053 | 0.111 | Adenylate kinase inhibitor | |||
| 0.081 | 0.023 | 0.081 | Protein kinase C eta inhibitor | |||
| 0.092 | 0.035 | 0.092 | Glutamate dehydrogenase inhibitor | |||
| 0.139 | 0.083 | 0.443 | Hemostatic | 0.443 0.005 CID_154699559 | CID_154699559 | |
| 0.159 | 0.104 | 0.166 | P-glycoprotein inhibitor | 0.166 0.094 CID_154699559 | CID_154699559 | |
| 0.106 | 0.051 | 0.106 | Nitric-oxide synthase inhibitor | |||
| 0.107 | 0.053 | 0.213 | UDP-glucose 4-epimerase inhibitor | 0.213 0.016 CID_154699559 | CID_154699559 | |
| 0.07 | 0.016 | 0.07 | NMDA receptor subunit 3B antagonist | |||
| 0.081 | 0.028 | 0.081 | NMDA receptor agonist | |||
| 0.063 | 0.01 | 0.063 | Dopamine D5 agonist | |||
| 0.098 | 0.046 | 0.151 | NADH dehydrogenase inhibitor | 0.151 0.017 CID_154699559 | CID_154699559 | |
| 0.078 | 0.027 | 0.078 | NMDA 2C receptor antagonist | |||
| 0.104 | 0.054 | 0.104 | Alpha adrenoreceptor antagonist | |||
| 0.08 | 0.03 | 0.08 | Protein kinase C beta inhibitor | |||
| 0.054 | 0.005 | 0.054 | Ceramide glucosyltransferase inhibitor | 0.049 0.007 CID_154699559 | ||
| 0.189 | 0.14 | 0.189 | Neuropeptide Y2 antagonist | |||
| 0.099 | 0.049 | 0.169 | Triose-phosphate isomerase inhibitor | 0.169 0.015 CID_154699559 | CID_154699559 | |
| 0.081 | 0.033 | 0.081 | Phospholipase D inhibitor | |||
| 0.061 | 0.014 | 0.061 | Dopamine beta hydroxylase inhibitor | |||
| 0.066 | 0.018 | 0.066 | Topoisomerase II beta inhibitor | 0.049 0.035 CID_154699559 | ||
| 0.066 | 0.019 | 0.066 | Potassium channel (Inward rectifier) blocker | |||
| 0.092 | 0.045 | 0.092 | Inducible nitric-oxide synthase inhibitor | |||
| 0.12 | 0.073 | 0.216 | DNA repair enzyme inhibitor | 0.216 0.007 CID_154699559 | CID_154699559 | |
| 0.09 | 0.044 | 0.09 | D-Ala-D-Ala ligase inhibitor | |||
| 0.229 | 0.183 | 0.229 | 15-Lipoxygenase inhibitor | |||
| 0.049 | 0.004 | 0.049 | Estrogen-related receptor gamma antagonist | |||
| 0.145 | 0.1 | 0.373 | Nitric oxide antagonist | 0.373 0.029 CID_154699559 | CID_154699559 | |
| 0.091 | 0.046 | 0.091 | Carbonic anhydrase VI inhibitor | |||
| 0.136 | 0.092 | 0.14 | Heat shock protein 70 antagonist | 0.14 0.077 CID_154699559 | CID_154699559 | |
| 0.061 | 0.02 | 0.061 | Squalene epoxidase inhibitor | |||
| 0.127 | 0.086 | 0.127 | Nav1.6 sodium channel blocker | |||
| 0.139 | 0.098 | 0.139 | CF transmembrane conductance regulator agonist | |||
| 0.083 | 0.043 | 0.083 | GABA aminotransferase inhibitor | 0.072 0.058 CID_154699559 | ||
| 0.081 | 0.041 | 0.081 | Aminopeptidase I inhibitor | |||
| 0.087 | 0.048 | 0.087 | Opioid kappa receptor antagonist | |||
| 0.093 | 0.054 | 0.093 | Opioid antagonist | |||
| 0.088 | 0.051 | 0.088 | Vanilloid agonist | |||
| 0.101 | 0.064 | 0.101 | Aminopeptidase B inhibitor | |||
| 0.124 | 0.088 | 0.124 | Neurotrophic factor | 0.114 0.105 CID_154699559 | ||
| 0.083 | 0.047 | 0.109 | Na+ K+ transporting ATPase inhibitor | 0.109 0.024 CID_154699559 | CID_154699559 | |
| 0.041 | 0.005 | 0.041 | Calcium-sensing receptor antagonist | |||
| 0.249 | 0.215 | 0.525 | Apoptosis agonist | 0.525 0.067 CID_154699559 | CID_154699559 | |
| 0.08 | 0.046 | 0.08 | Alpha 1b adrenoreceptor antagonist | |||
| 0.05 | 0.021 | 0.05 | Histamine H2 receptor agonist | |||
| 0.088 | 0.058 | 0.088 | Interleukin 5 antagonist | 0.087 0.059 CID_154699559 | ||
| 0.079 | 0.05 | 0.079 | Keratolytic | |||
| 0.033 | 0.004 | 0.033 | Alpha 2c adrenoreceptor agonist | |||
| 0.032 | 0.004 | 0.032 | Estrogen-related receptor gamma agonist | |||
| 0.055 | 0.028 | 0.055 | Dopamine transporter inhibitor | |||
| 0.034 | 0.008 | 0.035 | 1,3-Beta-glucan synthase inhibitor | 0.035 0.007 CID_154699559 | CID_154699559 | |
| 0.121 | 0.095 | 0.121 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.086 | 0.06 | 0.086 | Histamine N-methyltransferase inhibitor | |||
| 0.211 | 0.186 | 0.48 | Immunosuppressant | 0.48 0.038 CID_154699559 | CID_154699559 | |
| 0.079 | 0.054 | 0.099 | Interferon agonist | 0.099 0.029 CID_154699559 | CID_154699559 | |
| 0.055 | 0.031 | 0.112 | Factor IXa inhibitor | 0.112 0.007 CID_154699559 | CID_154699559 | |
| 0.063 | 0.039 | 0.063 | Purinergic P2X1 antagonist | |||
| 0.065 | 0.042 | 0.102 | Neuraminidase (influenza) inhibitor | 0.102 0.016 CID_154699559 | CID_154699559 | |
| 0.045 | 0.022 | 0.045 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | |||
| 0.065 | 0.042 | 0.065 | 5 Hydroxytryptamine 2A agonist | |||
| 0.056 | 0.034 | 0.072 | Leukotriene B4 antagonist | 0.072 0.019 CID_154699559 | CID_154699559 | |
| 0.182 | 0.16 | 0.182 | Lipoxygenase inhibitor | |||
| 0.113 | 0.092 | 0.113 | Nav1.2 sodium channel blocker | |||
| 0.049 | 0.028 | 0.049 | Oleamide hydrolase inhibitor | |||
| 0.056 | 0.035 | 0.056 | Immunoglobulin Fc receptor antagonist | |||
| 0.067 | 0.046 | 0.067 | Dopamine agonist | |||
| 0.04 | 0.019 | 0.04 | Phosphoglycerate kinase inhibitor | |||
| 0.026 | 0.006 | 0.059 | Ileal bile acid transport inhibitor | 0.059 0.003 CID_154699559 | CID_154699559 | |
| 0.06 | 0.04 | 0.06 | Alpha 1d adrenoreceptor antagonist | |||
| 0.04 | 0.021 | 0.04 | Estrogen receptor alpha agonist | |||
| 0.091 | 0.072 | 0.091 | Bile acid receptor antagonist | |||
| 0.04 | 0.021 | 0.04 | Estradiol 17 beta-dehydrogenase 2 inhibitor | |||
| 0.073 | 0.057 | 0.073 | Analgesic, opioid | |||
| 0.054 | 0.038 | 0.054 | Acyl-CoA dehydrogenase inhibitor | |||
| 0.074 | 0.058 | 0.074 | Estrogen receptor alpha antagonist | |||
| 0.028 | 0.012 | 0.046 | Vanilloid 2 agonist | 0.046 0.003 CID_154699559 | CID_154699559 | |
| 0.051 | 0.035 | 0.051 | Estrogen agonist | |||
| 0.044 | 0.028 | 0.044 | Oxytocin agonist | |||
| 0.122 | 0.107 | 0.272 | Insulin secretagoues | 0.272 0.016 CID_154699559 | CID_154699559 | |
| 0.063 | 0.048 | 0.078 | Interferon inducer | 0.078 0.026 CID_154699559 | CID_154699559 | |
| 0.04 | 0.025 | 0.04 | CF transmembrane conductance regulator antagonist | |||
| 0.031 | 0.016 | 0.031 | Purinergic P2Y15 antagonist | |||
| 0.104 | 0.089 | 0.104 | Interleukin 8 antagonist | |||
| 0.034 | 0.02 | 0.034 | Estrogen-related receptor beta antagonist | |||
| 0.124 | 0.11 | 0.124 | Phospholipase A2 inhibitor | |||
| 0.119 | 0.105 | 0.119 | Farnesoid X receptor antagonist | |||
| 0.183 | 0.17 | 0.183 | 12-Lipoxygenase inhibitor | |||
| 0.1 | 0.086 | 0.223 | Topoisomerase II inhibitor | 0.223 0.029 CID_154699559 | CID_154699559 | |
| 0.123 | 0.109 | 0.123 | MAP3K9 inhibitor | |||
| 0.044 | 0.031 | 0.044 | Dopamine D2 agonist | |||
| 0.068 | 0.058 | 0.068 | Porphobilinogen synthase inhibitor | |||
| 0.071 | 0.06 | 0.071 | NAD(P)H dehydrogenase (quinone) inhibitor | |||
| 0.059 | 0.049 | 0.059 | Heme oxygenase stimulant | |||
| 0.09 | 0.08 | 0.09 | Nav1.1 sodium channel blocker | |||
| 0.108 | 0.099 | 0.108 | NADPH oxidase inhibitor | |||
| 0.082 | 0.073 | 0.125 | ATPase (Vacuolar H+) inhibitor | 0.125 0.016 CID_154699559 | CID_154699559 | |
| 0.098 | 0.089 | 0.098 | Nav1.5 sodium channel blocker | |||
| 0.06 | 0.051 | 0.06 | Leukotriene antagonist | |||
| 0.02 | 0.011 | 0.02 | Alpha 2b adrenoreceptor agonist | |||
| 0.111 | 0.103 | 0.248 | Lipid peroxidase inhibitor | 0.248 0.027 CID_154699559 | CID_154699559 | |
| 0.043 | 0.035 | 0.127 | Phosphorylase inhibitor | 0.127 0.009 CID_154699559 | CID_154699559 | |
| 0.065 | 0.059 | 0.065 | Secretase beta inhibitor | |||
| 0.069 | 0.063 | 0.151 | Topoisomerase II alpha inhibitor | 0.151 0.023 CID_154699559 | CID_154699559 | |
| 0.027 | 0.022 | 0.027 | Liver X receptor beta antagonist | |||
| 0.019 | 0.014 | 0.028 | Antibiotic Anthracycline-like | 0.028 0.004 CID_154699559 | CID_154699559 | |
| 0.055 | 0.05 | 0.088 | Neuraminidase inhibitor | 0.088 0.02 CID_154699559 | CID_154699559 | |
| 0.064 | 0.06 | 0.064 | Catalase inhibitor | |||
| 0.051 | 0.047 | 0.051 | Epithelial sodium channel blocker | |||
| 0.041 | 0.038 | 0.041 | Heme oxygenase inhibitor | |||
| 0.016 | 0.013 | 0.016 | KiSS-1 receptor antagonist | |||
| 0.03 | 0.028 | 0.03 | Glutamate (mGluR3) agonist | |||
| 0.059 | 0.056 | 0.059 | Sphingosine 1-phosphate receptor 4 agonist | |||
| 0.054 | 0.051 | 0.054 | Opioid delta receptor antagonist | |||
| 0.05 | 0.047 | 0.05 | Sphingosine kinase 2 inhibitor | |||
| 0.02 | 0.018 | 0.02 | Neuraminidase (Influenza B) inhibitor | |||
| 0.094 | 0.093 | 0.127 | DNA polymerase I inhibitor | 0.127 0.063 CID_154699559 | CID_154699559 | |
| 0.036 | 0.035 | 0.036 | Estradiol 17 beta-dehydrogenase inhibitor | |||
| 0.057 | 0.059 | 0.117 | Phosphofructokinase-1 inhibitor | 0.117 0.026 CID_154699559 | CID_154699559 | |
| 0.045 | 0.052 | 0.055 | Factor III inhibitor | 0.055 0.024 CID_154699559 | CID_154699559 | |
| 0.03 | 0.037 | 0.078 | Antibiotic Aminoglycoside-like | 0.078 0.005 CID_154699559 | CID_154699559 | |
| 0.05 | 0.06 | 0.363 | Selectin antagonist | 0.363 0.004 CID_154699559 | CID_154699559 | |
| 0.039 | 0.054 | 0.053 | Glucose-6-phosphate isomerase inhibitor | 0.053 0.026 CID_154699559 | CID_154699559 | |
| 0.073 | 0.089 | 0.148 | Transcription factor NF kappa B stimulant | 0.148 0.016 CID_154699559 | CID_154699559 | |
| 0.131 | 0.149 | 0.291 | Non-steroidal antiinflammatory agent | 0.291 0.03 CID_154699559 | CID_154699559 | |
| 0.035 | 0.055 | 0.056 | Neuraminidase (Influenza A) inhibitor | 0.056 0.016 CID_154699559 | CID_154699559 | |
| 0.083 | 0.103 | 0.182 | Beta glucuronidase inhibitor | 0.182 0.015 CID_154699559 | CID_154699559 | |
| 0.02 | 0.041 | 0.065 | Sodium/glucose cotransporter inhibitor | 0.065 0.004 CID_154699559 | CID_154699559 | |
| 0.019 | 0.04 | 0.075 | Sodium/glucose cotransporter 2 inhibitor | 0.075 0.004 CID_154699559 | CID_154699559 | |
| 0.016 | 0.04 | 0.058 | Protein 30S ribosomal subunit inhibitor | 0.058 0.006 CID_154699559 | CID_154699559 | |
| 0.035 | 0.06 | 0.064 | Aldose reductase inhibitor | 0.064 0.03 CID_154699559 | CID_154699559 | |
| 0.114 | 0.148 | 0.654 | Angiogenesis stimulant | 0.654 0.005 CID_154699559 | CID_154699559 | |
| 0.015 | 0.052 | 0.044 | Arginase inhibitor | 0.044 0.019 CID_154699559 | CID_154699559 | |
| 0.013 | 0.054 | 0.022 | Dopamine D1 agonist | 0.022 0.017 CID_154699559 | CID_154699559 | |
| 0.045 | 0.086 | 0.062 | Adenine nucleotide translocase inhibitor | 0.062 0.024 CID_154699559 | CID_154699559 | |
| 0.073 | 0.117 | 0.103 | Xanthine oxidase inhibitor | 0.103 0.057 CID_154699559 | CID_154699559 | |
| 0.066 | 0.115 | 0.084 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.084 0.074 CID_154699559 | CID_154699559 | |
| 0.029 | 0.082 | 0.105 | Protein 50S ribosomal subunit inhibitor | 0.105 0.012 CID_154699559 | CID_154699559 | |
| 0.17 | 0.223 | 0.241 | Caspase 3 stimulant | 0.241 0.12 CID_154699559 | CID_154699559 | |
| 0.168 | 0.235 | 0.388 | Apoptosis antagonist | 0.388 0.042 CID_154699559 | CID_154699559 | |
| 0.053 | 0.122 | 0.093 | Glycine receptor antagonist | 0.093 0.04 CID_154699559 | CID_154699559 | |
| 0.033 | 0.103 | 0.046 | Cytokine production stimulant | 0.046 0.04 CID_154699559 | CID_154699559 | |
| 0.072 | 0.143 | 0.155 | Toll-Like receptor 4 antagonist | 0.155 0.018 CID_154699559 | CID_154699559 | |
| 0.053 | 0.135 | 0.191 | Topoisomerase I inhibitor | 0.191 0.029 CID_154699559 | CID_154699559 | |
| 0.026 | 0.112 | 0.045 | Microtubule stabilization | 0.045 0.035 CID_154699559 | CID_154699559 | |
| 0.032 | 0.12 | 0.169 | Antineoplastic antibiotic | 0.169 0.027 CID_154699559 | CID_154699559 | |
| 0.118 | 0.206 | 0.397 | Tumour necrosis factor alpha release inhibitor | 0.397 0.027 CID_154699559 | CID_154699559 | |
| 0.065 | 0.163 | 0.093 | T cell inhibitor | 0.093 0.033 CID_154699559 | CID_154699559 | |
| 0.062 | 0.169 | 0.17 | AMP-activated protein kinase stimulant | 0.17 0.018 CID_154699559 | CID_154699559 | |
| 0.041 | 0.153 | 0.061 | Lipocortins synthesis agonist | 0.061 0.034 CID_154699559 | CID_154699559 | |
| 0.029 | 0.141 | 0.08 | Glucose-6-phosphate translocase inhibitor | 0.08 0.011 CID_154699559 | CID_154699559 | |
| 0.084 | 0.2 | 0.178 | Hexokinase inhibitor | 0.178 0.051 CID_154699559 | CID_154699559 | |
| 0.048 | 0.182 | 0.121 | DNA intercalator | 0.121 0.057 CID_154699559 | CID_154699559 | |
| 0.083 | 0.218 | 0.228 | NOS3 expression enhancer | 0.228 0.032 CID_154699559 | CID_154699559 | |
| 0.026 | 0.174 | 0.085 | Heparanase inhibitor | 0.085 0.005 CID_154699559 | CID_154699559 | |
| 0.073 | 0.221 | 0.157 | Diuretic | 0.157 0.072 CID_154699559 | CID_154699559 | |
| 0.087 | 0.238 | 0.182 | Interleukin 6 antagonist | 0.182 0.053 CID_154699559 | CID_154699559 | |
| 0.056 | 0.243 | 0.091 | Interleukin 12 antagonist | 0.091 0.07 CID_154699559 | CID_154699559 | |
| 0.021 | 0.209 | 0.062 | Nitric oxide donor | 0.062 0.044 CID_154699559 | CID_154699559 | |
| 0.117 | 0.306 | 0.329 | Alpha-glucosidase inhibitor | 0.329 0.146 CID_154699559 | CID_154699559 | |
| 0.045 | 0.24 | 0.099 | Thioredoxin inhibitor | 0.099 0.049 CID_154699559 | CID_154699559 | |
| 0.077 | 0.277 | 0.271 | Platelet antagonist | 0.271 0.064 CID_154699559 | CID_154699559 | |
| 0.037 | 0.299 | 0.258 | Thrombolytic | 0.258 0.032 CID_154699559 | CID_154699559 | |
| 0.061 | 0.326 | 0.346 | Platelet adhesion inhibitor | 0.346 0.02 CID_154699559 | CID_154699559 | |
| 0.006 | 0.273 | 0.021 | Motilin receptor agonist | 0.021 0.02 CID_154699559 | CID_154699559 | |
| 0.093 | 0.363 | 0.137 | CC chemokine 6 receptor antagonist | 0.137 0.047 CID_154699559 | CID_154699559 | |
| 0.013 | 0.327 | 0.03 | Toll-Like receptor 4 agonist | 0.03 0.012 CID_154699559 | CID_154699559 | |
| 0.038 | 0.367 | 0.211 | Anticoagulant | 0.211 0.049 CID_154699559 | CID_154699559 | |
| 0.035 | 0.421 | 0.199 | Cell adhesion inhibitor | 0.199 0.025 CID_154699559 | CID_154699559 | |
| 0.1 | 0.53 | 0.665 | Antiinflammatory | 0.665 0.038 CID_154699559 | CID_154699559 | |
| 0.017 | 0.482 | 0.094 | Cell adhesion molecule inhibitor | 0.094 0.039 CID_154699559 | CID_154699559 | |
| 0.043 | 0.527 | 0.192 | Angiogenesis inhibitor | 0.192 0.179 CID_154699559 | CID_154699559 | |
| 0.023 | 0.77 | 0.269 | Immunomodulator | 0.269 0.101 CID_154699559 | CID_154699559 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |